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Abstract  
Amyloid-beta (A) plaques are a hallmark of Alzheimer’s disease (AD) that can be 
assessed by amyloid imaging (e.g. Pittsburgh B compound [PiB]) and summarized as a 
scalar value. Summary values may have clinical utility but are an average over many regions 
of interest, potentially obscuring important topography. This study investigates the 
longitudinal evolution of amyloid topographies in cognitively normal older adults who had 
normal (N = 131) or abnormal (N= 26) PiB scans at baseline. At 3 year follow-up, 16 
participants with a previously normal PiB scan had conversion to PiB scans consistent with 
preclinical AD. We investigated the multivariate relationship (canonical correlation) 
between baseline and follow-up PiB topographies. Further, we used penalized regression to 
investigate the added information derived from PiB topography compared to summary 
measures. PiB accumulation can be local, i.e., a topography predicting the same topography 
in the future, and/or distributed, i.e., one topography predicting another.  Both local and 
distributed PiB accumulation was associated with conversion of PiB status. Additionally, 
elements of the multivariate topography, and not the commonly used summary scalar, 
correlated with future PiB changes. Consideration of the entire multivariate PiB topography 
provides additional information regarding the development of A pathology in very early 
preclinical AD. 
  
 3 
Introduction 
Alzheimer’s disease (AD) is characterized by a long preclinical period wherein 
pathology accumulates in the absence of overt symptoms (Price et al., 2009). The deposition 
of amyloid-beta (A), measured via positron emission tomography (PET) using Pittsburgh 
Compound B (PiB) (Klunk et al., 2004), is one of the earliest measurable pathological 
changes in AD (Braak and Del Tredici, 2012, Jack et al., 2013) and can be monitored 
longitudinally (Sojkova et al., 2011, Villemagne et al., 2011, Vlassenko et al., 2011). The 
results of PiB scans are often summarized into a single scalar metric defined as an average 
over a group of regions known to accumulate the most of A plaques in symptomatic AD. 
PiB scans assessed in this way are dichotomized as either PiB negative (PiB–) or PiB 
positive (PiB+) (Mintun et al., 2006). A PiB+ scan in a cognitively normal individual is 
interpreted as presumptive evidence for preclinical AD (Sperling et al., 2011, Jack et al., 
2012, Morris et al., 2014) and predicts clinical progression (Morris et al., 2009). 
Dichotomizing PiB status is potentially clinically useful but reduces complex and potentially 
informative topographies to a single scalar metric. 
 The earliest detectably abnormal amyloid topography is relatively focal but 
becomes more expansive as the disease progresses (Thal et al., 2002, Braak et al., 2011). 
Understanding of this early topography, how it differs from the topography of the highest 
PiB retention at the more advanced stages of AD, and how it progresses in the early stage of 
the disease remains unclear. Multivariate statistical techniques, well suited for examining 
local and distributed phenomena, may help to characterize better the relationships in 
longitudinal amyloid topographies as assessed by PiB. 
 In this study we followed 157 cognitively normal participants who were PiB– (N = 
131) or PiB+ (N = 26) at baseline as assessed by a summary scalar value of mean cortical 
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standardized uptake value ratio (SUVR). These participants were followed longitudinally 
(mean follow up: ~3 years). In participants who developed significant PiB accumulation 
(i.e., became PiB+), we investigated the topographic progression of PiB accumulation using 
canonical correlation. Canonical correlation identifies pairs of highly correlated 
topographies. We then compared the ability of the single scalar value and topographic 
measures to capture the underlying PiB accumulation associated with the development of 
preclinical AD.  
 5 
Methods 
Subjects: Participants were community dwelling volunteers (age range 45-85 years) 
enrolled in the Adult Children Study project at the Washington University in St Louis Knight 
Alzheimer Disease Research Center (ADRC). All participants were cognitively normal, both 
at baseline and at follow-up PiB scans, as assessed by a Clinical Dementia Rating (CDR) 
score of 0 (Morris, 1993) and the Mini-mental status exam (MMSE). Participants were in 
good general health with no neurological, psychiatric, or systemic medical illness that could 
disrupt longitudinal participation. Each participant underwent MRI and PiB PET (described 
below). Baseline scans were dichotomized as either PiB– or PiB+ (criteria described below) 
and a second scan was performed on average 3.29 years later (standard deviation= 1.22 
years; min = 0.96 years; max = 6.47 years). Participants were divided into three groups 
based on their PiB status at baseline and follow up: CNnn (cognitively normal, PiB– at both 
scans, N=115), CNnp (cognitively normal, PiB– at first scan but PiB+ at second scan, N=16), 
or CNpp (cognitively normal, PiB+ at both scans, N=26). Complete demographic information 
is shown in Table 1. 
MRI Assessment: MRI consisted of an MPRAGE T1-weighted image collected on a Siemens 
(Erlangen, Germany) MR scanner. Images are processed using FreeSurfer software version 
5.1 (Martinos Center for Biomedical Imaging, Charlestown, MA) (Fischl et al., 2002). All 
FreeSurfer parcelations were assessed for accuracy by a skilled investigator (KAF). Only 
grey matter regions were included in this analysis.  
PET Assessment: The PiB PET assessment has been previously described in detail (Su et al., 
2013, Su et al., 2014). Imaging was conducted on a Siemens 962 HR+ ECAT PET scanner or a 
Siemens Biograph 40 scanner. PET data were analyzed using previously developed methods  
(Su et al., 2013, Su et al., 2015). FreeSurfer segmentation (Fischl et al., 2002) 
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(http://freesurfer.net/) was used as the basis for quantitative analysis to obtain regional 
standardized uptake value ratio (SUVR) with cerebellar gray matter serving as the reference 
region. Partial volume correction was also performed using a regional spread function 
(RSF) technique (Rousset et al., 1998, Su et al., 2015).   
 PiB positivity was defined using the mean cortical (MC) SUVR across the precuneus, 
prefrontal, gyrus rectus and temporal Freesurfer ROIs (Morris et al., 2010). A cut-off value 
of 1.42 was used which is comparable to a mean cortical binding potential of 0.18 that was 
previously defined (Mintun et al., 2006, Su et al., 2013). Characteristic SUVR images are 
presented in Supplemental Figure 1.  The equivalence for a MC-SUVR of 1.42 and MC-BP of 
0.18 was previously determined using regression in an independent sample (unpublished 
data). Due to the criticality of this cut-off for subsequent analyses, primary results are also 
replicated using an alternative cut-off determined from this sample (Supplemental 
Material). 
Canonical Correlation Analysis: We investigated the progression of PiB topography in CNnp, 
CNnn, and CNpp groups separately. To do this, we calculated the canonical correlation 
between the PiB topography at baseline and the PiB topography at follow-up using 42 ROIs 
(Hotelling, 1936, Hardle and Simar, 2007). A canonical correlation is the weighted average 
of variables (termed canonical variables) in one distribution that are maximally correlated 
with the weighted average of variables from another distribution. There can be multiple 
significant canonical correlations that isolate unique variance (similar to PCA components).  
Let 𝑋1, 𝑋2 ∈ ℝ
𝑁×𝑀 index the regional PiB SUVR in N subjects and M=42 ROIs at time-
point 1 and 2, respectively.  Define: 
Σ = [
Σ1 Σ12
Σ21 Σ2
] = [
𝑋1
𝑇𝑋1 𝑋1
𝑇𝑋2
𝑋2
𝑇𝑋1 𝑋2
𝑇𝑋2
] 
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In this case,  is rank deficient which precludes matrix inversion. Therefore, define Σ̂ =
(1 − 𝛼)Σ + 𝛼Δ where  is an arbitrary parameter and  is a shrinkage target (Schafer and 
Strimmer, 2005). For this analysis,  is calculated in closed form as previously described 
(Ledoit and Wolf, 2003);  is defined as the diagonal matrix of  which ensures that Σ̂ is full 
rank (Ledoit and Wolf, 2004). This approach was recently applied to analyze functional MRI 
data (Brier et al., 2015). 
 The number of significant canonical correlations is defined as the dimensionality of 
Σ̂12. Here we estimate this dimensionality using an information criterion (Minka, 2000). For 
every significant canonical correlation there exist two canonical variables: one 
corresponding to the baseline PiB topography and another corresponding to the follow up 
PiB topography. Let ai be the ith canonical variable corresponding to the baseline PiB 
topography; ai is defined as the ith eigenvector of Σ̂1
−1Σ̂12Σ̂2
−1Σ̂21. Similarly, let bi be the ith 
canonical variable corresponding to the follow up PiB topography; bi is defined as the ith 
eigenvector of Σ̂2
−1Σ̂21Σ̂1
−1Σ̂12. The values of ai and bi are unit norm and maximize the 
correlation between 𝑎𝑖
𝑇𝑋1 and 𝑏𝑖
𝑇𝑋2. 
Penalized Regression: We fit an elastic net penalized regression model which uses the linear 
combination of an L1 and L2 norm of the calculated  values as a penalty (also known as 
Least Absolute Shrinkage and Selection Operator [LASSO] and ridge regression, 
respectively) (Tibshirani, 1996, Hastie et al., 2001, Zou and Hastie, 2005). Penalized 
regression differs from Ordinary Least Squares (OLS) regression in that it enforces a 
penalty term that forces some favorable property on the resulting regression s.  The L1 
penalty (LASSO) penalizes non-zero  values and thus forces small  values to 0 and retains 
a small number of non-zero values. This results in a model that is more easily 
interpretable (i.e., has only a few terms to consider). However, in data that are highly co-
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linear the decision to retain one variable and discard a highly correlated variable is 
arbitrary (Zou and Hastie, 2005). The elastic net accommodates this data feature by 
allowing highly correlated predictor variables to enter the model simultaneously. This 
flexibility is accomplished by relaxing the L1 penalty with some fraction of an L2 penalty. 
We fit two separate elastic net models: The first uses follow-up MC SUVR as an 
outcome variable and the second uses percent change in MC SUVR as an outcome variable. 
Let 𝒚 = [𝑦1, 𝑦2, … , 𝑦𝑁] ∈ ℝ be the outcome variable of interest, either follow-up MC SUVR or 
the percent change in MC SUVR between baseline and follow-up. Further, let 𝑋 = ℝ𝑁×(𝑀+1) 
index the regional PiB SUVR in N subjects and M=40 ROIs. The M+1th region is the baseline 
MC-SUVR value which is included in order to investigate its sufficiency as a predictor. All 
variables were mean centered and made unit variance (z-scored). The estimate of penalized 
regression coefficients then has the form: 
argmin
?̂?
‖𝒚 − 𝑋?̂?‖
2
+ 𝜆 ((1 − 𝛼)‖?̂?‖
2
+ 𝛼‖?̂?‖
1
) 
The first term is OLS regression. The second and third terms are the L2 and L1 norms, 
respectively.  determines the overall penalty severity and  determines the relative 
contribution of the L1 and L2 penalty. Both parameters are selected by leave-one-out cross 
validation.  
 To compare the power of baseline MC -SUVR and the entire topography to predict 
follow-up MC-SUVR or percentage change in MC -SUVR we compared the adjusted-R2 
values: 
𝑎𝑑𝑗 𝑅2 = 1 −
(1−𝑅2)(𝑁−1)
𝑁−𝑑𝑓−1
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For OLS, the df is the number of predictors. Similarly, for LASSO regression the number of df 
is the number of non-zero  values. However, in elastic net regression the number of df is 
complicated by the potential for co-linearity in the selected predictors. Thus, df is defined 
as: 
𝑑𝑓 = 𝑇𝑟 (𝑋𝒜(𝑋𝒜
𝑇 𝑋𝒜 + (𝜆 ∙ (1 − 𝛼))𝐼)
−1
𝑋𝒜
𝑇 ) 
where Tr indicates the trace and 𝒜 indicates the active predictor set (Zou and Hastie, 
2005). 
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Results 
 We first investigated the evolution of PiB topography in the CNnp group. The 
number of significant canonical correlations was determined to be 3 using an information 
criteria (Minka, 2000). The first canonical correlation was characterized by the baseline 
topography in Figure 1A and the follow-up topography in Figure 1B. The baseline 
topography was dominated by large positive weights in the posterior cingulate, precuneus, 
and superior temporal regions balanced by negative weights in lateral frontal regions. At 
follow-up the topography was similar but now also included inferior and lateral temporal 
regions. These topographies were highly correlated (Figure 1C; r = 0.58, p < 10–4). For 
example, the precuneus and temporal regions are positive in both topographies and lateral 
frontal regions are strongly negative. The original regional data are then projected onto 
these topographies yielding a single scalar value for each subject at baseline and follow-up. 
Put another way, the weighted average of PiB binding (weighted according to the loadings 
in the topographies) was calculated at baseline and follow-up. These baseline and follow-up 
scalar values were highly correlated (Figure 1D; r = 0.99; p < 10–10) with follow-up 
significantly higher. Thus, this canonical correlation represents the accumulation of A 
locally in regions already affected. 
 The second canonical correlation, isolated after removing the variance related to the 
first canonical correlation, had a different pattern. The topographies of PiB for the baseline 
and follow-up scan are shown in Figure 1E and Figure 1F, respectively. The baseline 
topography was dominated by large positive weights in posterior cingulate, precuneus, and 
lateral parietal regions. In contrast, frontal regions dominated the follow-up topography. In 
contrast to the first canonical variable, the topographies were not as strongly correlated 
(Figure 1G; r = 031; p = 0.04). This indicates that baseline PiB topography predicts PiB 
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values in a different topography at follow-up. Projection of the original data onto these 
topographies resulted in a strong positive correlation (Figure 1H; r = 0.99; p < 10–10). The 
prediction of a distinct topography at follow up based on a different topography at baseline 
suggests that this canonical correlation represents the expansion of A topography to 
additional regions in the CNnp group. 
 The third canonical correlation has yet a different pattern. The topographies of PiB 
for the baseline and follow-up scan are shown in Figure 1I and Figure 1J and were 
moderately correlated (Figure 1K; r = 0.47, p = 0.002). The baseline topography was 
dominated by the anterior cingulate while the follow up topography was dominated by 
precuneus and subcortical regions. Projection of the original data onto this topography 
resulted in a strong positive correlation (Figure 1L; r = 0.99; p < 10–10). This canonical 
correlation represents a combination of local and distributed processes distinct from the 
two aforementioned processes. These canonical correlation analyses were replicated using 
an alternative cut-off (Supplemental Material). 
 One analytic decision present in the previous results is the averaging of homotopic 
regions into a single bilateral ROI. We sought to determine whether this assumption 
(similar results on the left and right) was supported by the data. To accomplish this, the 
number of columns in 𝑋 was doubled to 2𝑀 corresponding to left and right regional SUVR 
values being represented separately. The number of canonical correlations in this 
lateralized data set was determined to be 3 by an information criteria (Minka, 2000). This 
was the same number of canonical correlations identified in the homotopic analysis 
described above. There were two critical analytic questions to be addressed: 1) were the 
topographies isolated in the lateralized analysis symmetric across the mid-sagittal plane 
and 2) were the same topographies isolated in the lateralized analysis similar to those in  
the homotopic analysis. To address the first question, within a single topography the 
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loadings on the left were regressed onto the loadings on the right. For all topographies (3 
canonical correlations with a baseline and follow-up topography ) the left and right loadings 
were strongly related (all p < 0.05). In each case, the 95% confidence intervals on the 
regression  crossed 1, suggesting equal values for the left and the right hemispheres. 
Nevertheless, the maximum likelihood  estimate favored a larger representation in the left 
hemisphere compared to the right hemisphere but this bias was not significant. We next 
examined whether the topographies isolated in the lateralized analysis were similar to the 
topographies isolated in the homotopic analysis. For each canonical correlation (both 
baseline and follow-up), the topography resulting from the homotopic analysis was highly 
correlated between the left and right (analyzed separately) hemisphere topographies 
resulting from the lateralized analysis (all r > 0.65; all p < 0.001). These data suggest a bias 
towards representation of the left hemisphere but this difference does not lead to 
significantly different PiB accumulation with respect to hemisphere. 
 A single canonical correlation described the relationship between baseline and 
follow-up PiB topographies in the CNnn group (Figure 2A and B). The baseline and follow-
up topographies were not correlated (Figure 2C) and did not demonstrate any obvious 
biological topography. Furthermore, the projected PiB values did not show systematic 
increases (Figure 2D), indicating no accumulation, consistent with their CNnn status. 
A single canonical correlation described the relationship between baseline and 
follow-up PiB topographies in the CNpp group (Figure 3). The baseline topography (Figure 
3A) was not significantly correlated with the follow-up topography (Figure 3B; r = 0.12, p = 
0.44). However, the projected PiB values were strongly correlated (r = 0.99; p < 10–10) and a 
dramatic accumulation was seen at follow-up, as reflected by data above the identity line 
(Figure 3D). These results suggest that CNpp individual at baseline continues to have 
significant accumulation longitudinally. 
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We next turned to the question of defining the correlates of future PiB accumulation 
in those who were PiB– at baseline. Accepting that the MC SUVR is a reliable measure of the 
level of AD pathology, can follow-up values be understood as a function of the baseline 
scan? Across all subjects, the baseline and follow-up MC SUVR were highly correlated 
(r=0.55, p < 10–11, Adj-R2=0.30) suggesting that, relative to the inter-individual variance, 
MC-SUVR values did not dramatically change over a period of 3 years. Importantly, only 
within just the CNnp group were the baseline and follow-up MC SUVR not correlated 
(r=0.24, p=0.36). Baseline MC-SUVR was also not correlated with the percent change in MC-
SUVR across scans (r=0.026, p=0.77, Adj-R2=–0.007). A negative Adj-R2 indicates poor 
model fit. Notably, the baseline MC-SUVR and percent change in MC SUVR was negatively 
correlated in the CNpp group (r=–0.54, p=0.0047), suggesting a slowing of PiB accumulation 
within this topography. Thus, an open question is what features in the baseline topography 
correlates with future change in MC-SUVR. 
 To investigate which features of the baseline topography correlate with the follow-
up MC-SUVR and percent change in MC-SUVR we fit two separate elastic net models using 
individual regional SUVR values as predictors. The  coefficients corresponding to the 
minimum cross-validation error for each model are shown in Table 2 and depicted visually 
in Figure 4. Positive values predict relatively higher MC-SUVR or positive changes in MC 
SUVR in the first (predicting MC-SUVR) and second model (predicting percent change in 
MC-SUVR) and negative values predict relatively lower MC-SUVR or negative changes in 
MC- SUVR. Importantly, the baseline MC-SUVR only entered the model for predicting follow-
up MC-SUVR and not for predicting the change in MC-SUVR. The correlation between the 
predicted follow-up MC-SUVR and the actual MC-SUVR was significantly correlated (r=0.73, 
p<10–22) and after correcting for the number of predictors was better than baseline MC 
SUVR alone (Adj-R2=0.50 compared to 0.30). Similarly, the predicted percent change in MC-
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SUVR was significantly correlated with the actual percent change in MC-SUVR (r=0.54, 
p<10–10) and, after correcting for the number of predictors, was better than baseline MC-
SUVR alone (Adj-R2=0.25 compared to –0.007).
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Discussion 
This report uses two multivariate techniques (canonical correlation and penalized 
regression) to describe expanding A topographies, as assessed by PiB, and identifies 
patterns of deposition correlated with future A accumulation. Canonical correlation finds 
topographies that represent local and distributed accumulation in those who develop 
preclinical AD as assessed by a scalar cut-off. Critically, within cognitively normal 
individuals similar accumulation is absent in the group that remains PiB–  at both time 
points but is present in those who became PiB+ at follow up or who remained PiB+ at both 
time points.  Evidence of A pathology (e.g., in the CNnp group) is sufficient for classification 
as Stage 1 preclinical AD (Sperling et al., 2011, Jack et al., 2012). Given that these 
participants became A+ over a three year interval, this group represents the very earliest 
identifiable stages of preclinical AD. One method of operationalizing these criteria is 
through a scalar cut off applied to some mean A binding index (Mintun et al., 2006). This is 
a potentially clinically useful method for summarizing the data and is predictive of eventual 
symptomatic conversion (Morris et al., 2009). However, the baseline MC SUVR failed to 
strongly correlate with future changes in MC SUVR, limiting its’ utility in early disease 
stages. In contrast, the multivariate topography, not restricted to regions typically involved 
in the late stages of AD, strongly correlated with change in MC SUVR in a penalized 
regression analysis. Overall, these data demonstrate that accounting for the multivariate A 
topography may help to understand and characterize the development of AD pathology 
over the different stages of the disease. 
The application of multivariate statistics to the study of A topographies allows for 
the investigation of novel neurobiology. Previous work employing mass univariate 
approaches necessarily included a data reduction step, e.g., averaging over many regions of 
interest. This approach is powerful when the relevant topography is known. However, in 
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the earliest stages of preclinical AD the relevant topography is unknown. Canonical 
correlation and penalized regression consider the entire topography in a minimally biased 
manner in order to maximize explanatory power. In this report, the additional power 
resulting from considering the entire distribution is leveraged to describe the topography of 
A associated with conversion to preclinical AD. Importantly, the identified topography is 
distinct from the maximally effected topography in late stage AD.  
A critical analytic decision in the analysis of PiB data is resolution at which the 
analysis should be conducted. Currently, three analytic strategies dominate the literature: 
analysis of 1) global PiB binding over the entire cortex, 2) composite PiB binding in an a 
priori topography, or 3) regional/voxel-wise PiB binding. The first two approaches are 
strong data reduction approaches that have demonstrated utility for predicting future 
symptomatic conversion (Morris and Price, 2001, Ma et al., 2014) though regional analysis 
may offer diagnostic advantages (Aizenstein et al., 2008). The notable feature of both of 
these approaches is the definition of a region of interest a priori (the whole cortex in the 
case of the former, specific topographies in the case of the latter). However, the relevant 
topography where A deposition maximally occurs changes with disease progression 
(Villain et al., 2012); the topography that predicts symptomatic conversion may not be 
useful for detecting changes associated with earliest disease onset. Regional analyses allow 
for the flexibility to identify novel topographies but can yield varied results owing to the 
increased number of degrees-of-freedom (Engler et al., 2006, Jack et al., 2009, Grimmer et 
al., 2010, Rinne et al., 2010, Villemagne et al., 2011, Kadir et al., 2012). The presently 
reported results make use of multivariate techniques well-suited to compiling regional data 
into meaningful topographies. Application of such approaches is especially important when 
the topographies of interest are not known a priori. 
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The conversion from A – to A + status necessarily involves deposition of 
additional Aβ. That additional deposition is not haphazard but usually follows a 
stereotypical progression (Braak and Braak, 1997, Thal et al., 2002). We report on distinct 
processes using canonical correlation analysis. We find evidence of a local and distributed 
process. In the local process, regions with Aβ deposition at baseline simply accumulate 
more Aβ plaques by the follow up scan. However, in the distributed process, Aβ in a 
particular topography correlates with Aβ deposition in a different topography. Specifically, 
this progression represents the well-documented spread of A deposition from posterior 
regions to more anterior regions (Thal et al., 2002).  
The penalized regression model identifies topography of A retention that 
correlates with future A accumulation, either total value or percent change. Critically, the 
summary scalar was not a strong correlate of future percent change in A burden. The 
regions with positive  values largely overlap with known areas of A retention early in the 
disease (Thal et al., 2002). However, not all regions overlap with previously defined 
summary metrics used for operationalizing the A + definition. Notably, the previous scalar 
metric was defined based on the observations in the symptomatic stage of AD and does not 
necessary reflect the spatial pattern of Aβ deposition in early preclinical stage (Mintun et al., 
2006). This may lead to a biased view of early Aβ burden using the MC SUVR approach. The 
caudate nucleus deserves specific discussion. While it is known that caudate develops A 
deposits throughout the disease (Thal et al., 2002), it is not commonly noted as a prominent 
initial contributor to A topography in late onset AD (but see (Kemppainen et al., 2007)). 
Nevertheless, the caudate nucleus is identified in both penalized regression models. 
However, it has been noted that individuals with autosomal dominant AD have particularly 
intense A retention in the striatum (Klunk et al., 2007). The independent evidence from 
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this study and the study of autosomal dominant AD suggests some important, or at least 
reliable, process may be ongoing in the striatum early in AD. 
 The penalized regression identified several regions which were negatively loaded in 
both regression models. The presence of these negatively loaded regions demonstrates that 
the A topography associated with advancing disease is specific. That is, A binding alone is 
not sufficient but rather it must be deposited in the disease causing topography. Amyloid in 
negatively loaded regions does not contribute to early disease pathophysiology. Indeed, A 
is only present in the primary motor and sensory cortices much later in the disease (Braak 
and Braak, 1997), likely after symptoms develop. This potentially reflects that participants 
who have A retention in the precentral gyrus are unlikely to be A – at baseline. Thus, 
negatively loaded regions may serve as control regions by accounting for binding that is not 
due to A or AD-related processes, especially at early disease stages. The presence of a 
negatively predictive region indicates that it is not simply high values of A retention that 
predict conversion to A + status, but rather Aβ deposition in a specific topography.  
 Only a small number of participants converted from A – status to A + status which 
limits the robustness of this study. Additionally, the definition of converter compared to 
non-converter is based on crossing an A threshold. While such thresholds have been 
demonstrated to be potentially clinically useful (Mintun et al., 2006, Morris et al., 2009), 
other choices for a cutoff may be equally valid. Regardless of the precise definition, the 
primary scientific points remain: local and distributed processes are involved in the 
conversion to preclinical AD and consideration of the entire multivariate A topography 
identifies correlates of advancing A accumulation. A related point pertains to the 
prognostic information related to individuals who remain A– for the duration of the study 
but accumulate more A than average. These individuals are likely at an increased risk for 
developing preclinical AD in the future but longer follow-up time is required. 
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 In summary, this study identified canonical correlations between baseline and 
follow-up PiB topographies in patients who converted from A – to A +. Penalized 
regression identified a topography association with future A accumulation. Future studies 
could validate these regression models for their predictive power.   
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Tables 
Table 1: Demographic Information 
Variable CNnn CNnp 
CNpp 
p 
N 115 16 26 N/A 
Age in years at baseline 
scan (SD) 
59.5 (8.77) 66.4 (8.67) 68.2 (6.3) <0.001 
Gender (M/F) 35/80 5/11 10/16 0.73 
Education in years (SD) 16.1 (2.4) 15.4 (2.5) 15.4 (2.4) 0.90 
APOE ε4+ (% Carriers) 23 (20%) 9 (56%) 17 (65%) <0.001 
MC SUVR at baseline 
(SD) 
0.97 (0.07) 1.17 (0.10) 2.12 (0.60) <0.001 
MC SUVR (Follow-up) 1.02 (0.09) 1.47 (0.31) 2.48 (0.56) <0.001 
MMSE at baseline) 29.3 (0.86) 29.3 (1.09) 28.9 (1.51) 0.73 
MMSE at follow-up) 29.4 (0.92) 29.4 (0.96) 29.0 (1.42) 0.89 
Follow-up time in years 
(SD) 
3.30 (1.45) 3.26 (1.20) 2.99 (1.26) 0.37 
Table 1 Caption: Mean (standard deviation) or counts for demographic variables. CNnn, 
cognitively normal individuals, PiB-negative at both scans; CNnp, cognitively normal, PiB–
negative at first scan but PiB-positive at second scan; M, males; F, females; APOE ε4, positive 
indicates at least one APOE ε4 allele; MC SUVR, mean cortical standard uptake volume ratio 
of PiB deposition MMSE, mini mental status exam SD, standard deviation 
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Table 2: Elastic Net Regression Coefficients 
 Predictor Value 
Region Follow-up MC-SUVR % Change in MC-SUVR 
Posterior Cingulate 0.032 0.023 
Rostral Middle Frontal  0.028  
Rostral Anterior Cingulate 0.027 0.014 
Precuneus 0.025  
Baseline MC-SUVR 0.021  
Caudate 0.017 0.011 
Frontal Pole 0.016 0.002 
Caudal Anterior Cingulate 0.010 0.004 
Caudal Middle Frontal 0.005  
Parahippocampal Gyrus 0.003  
Pericalcerine  –0.003 
Transverse Temporal –0.001  
Insula –0.004 –0.004 
Pre-central Gyrus –0.015 –0.016 
Post-central Gyrus –0.027 –0.023 
 
Table 2: Table of penalized (elastic net) regression coefficients. Blank spaces correspond to 
coefficients equal to zero.  
 25 
Figure Captions 
Figure 1 Caption: Canonical correlation analysis reveals distinct amyloid accumulation 
processes. The results corresponding to the first, second, and third canonical correlations 
are organized as individual rows. The first column (A, E, I) shows the canonical variable (a) 
corresponding to the baseline PiB topography. The second column (B, F, J) shows the 
canonical variable (b) corresponding to the follow up PiB topography. These topographies 
are unit norm. The third column (C, G, K) shows the correlation between the two canonical 
variables within a single canonical correlation. The fourth column (D, H, L) show the 
projection of the original data onto the canonical variables. Red line is the identity line. 
 
Figure 2 Caption: Canonical correlation analysis in the CNnn group reveals minimal amyloid 
accumulation. Canonical correlation analysis in the CNnn group using the same presentation 
style as Figure 1 in the main text. The critical feature here is that the correlated 
topographies do not exhibit marked accumulation (the data are along the identity line in D). 
 
Figure 3 Caption: Canonical correlation analysis in the CNpp group reveals substantial 
amyloid accumulation. Canonical correlation analysis in the CNpp group using the same 
presentation style as Figure 1 in the main text. The critical feature here is that the 
correlated topographies exhibit marked accumulation (the data are above the identity line 
in D). 
 
Figure 4 Caption: Topography of baseline PiB deposition that correlates with follow-up and % 
change in MC-SUVR. Graphical representation of the information in Table 2. First row shows 
MC definition. Color bar indicates regression  values. 
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Supplemental Figure 1 Caption: Baseline and Follow-up SUVR Images for the CNnn, CNnp and 
CNpp Group. Baseline and follow-up SUVR images for three randomly selected participants 
in each group.  
 
Supplemental Figure 2 Caption: Canonical Correlation Analysis of CNnp is Robust to Choice of 
Threshold. A critical analytic step is the definition of PiB+ vs. PiB–. The canonical correlation 
analysis was repeated for two different MC-SUVR thresholds. In each case, 3 significant 
canonical correlations were isolated. The correlation between the baseline and follow-up 
topographies in each canonical correlation was assessed. (A) The correlation matrix 
between the three baseline and follow-up topographies under the two thresholds are 
shown. The critical finding is in the off-diagonal box representing the cross correlation 
between the two thresholds. For each of the three topographies using a 1.42 threshold are 
identifiable using an alternative 1.20 threshold (see Supplemental Materials). (B) The 
individual topographies for each threshold are shown. The visual correspondence confirms 
the quantitative information in A. 
 
